Aussies ID Enzyme Responsible for Obesity
This article was originally published in PharmAsia News
Executive Summary
Australian researchers report identification of an enzyme responsible for causing obesity. Working at a Melbourne institute, the scientists said they discovered the role of the oxidase enzyme while working on other stem cell research. Their research offers a possibility ways can be developed to prevent the enzyme from communicating with fat cells and telling them to multiply. The discovery also suggests techniques could be developed to turn fat cells into heart cells and other parts of the body. (Click here for more
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.